| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner | 10% Owner
5 companies
Manning Paul B serves as a Director, 10% Owner at VRCA and has filed Form 4s across 5 companies. Across recent SEC filings that breaks down to 59 buys and 9 sells. Those positions are worth an estimated $39.7M at current prices.
Historically, Manning Paul B's trades have earned a middling insider score of 54/100 across 28 rated trades. Over a 12-month horizon, 45.8% of those trades were profitable, with an average 12-month return of -8.8%.
The biggest single holding is VRCA (~$16.8M) as Director, 10% Owner. Net of sales, the recent Form 4 record there shows accumulation of 33,465,310 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | LQDA Liquidia Corporation | Director | Sell | 200,000 | $63.91 | $12,782,058.70 | -20.0% | +11.4% | - | |
| Feb 23, 2026 | CADL Candel Therapeutics, Inc. | Director | Buy | 550,458 | $5.45 | $2,999,996.10 | +24.9% | +59.8% | - | |
| Nov 25, 2025 | VRCA Verrica Pharmaceuticals Inc. | Director, 10% Owner | Buy | 4,126,142 | $4.24 | $17,505,157.44 | -530.5% | +9.4% | - | |
| Sep 2, 2025 | LQDA Liquidia Corp | Director | Sell | 670,837 | $28.26 | $18,957,475.28 | -60.9% | +12.1% | +143.8% | |
| May 30, 2025 | TSHA Taysha Gene Therapies, Inc. | 10% Owner | Buy | 750,000 | $2.75 | $2,062,500.00 | +35.9% | +4.4% | +116.6% | |
| Dec 16, 2024 | CADL Candel Therapeutics, Inc. | Director | Buy | 1,250,000 | $6.00 | $7,500,000.00 | +2,325% | +43.5% | -6.7% | |
| Nov 22, 2024 | VRCA Verrica Pharmaceuticals Inc. | Director, 10% Owner | Buy | 22,921,348 | $0.00 | - | -135.3% | -25.4% | -57.7% | |
| Sep 12, 2024 | LQDA Liquidia Corp | Director | Buy | 337,078 | $8.90 | $2,999,994.20 | +70.3% | +12.6% | +167.4% | |
| Jun 27, 2024 | TSHA Taysha Gene Therapies, Inc. | 10% Owner | Buy | 1,333,333 | $2.25 | $2,999,999.25 | New | -7.2% | +9.9% | |
| Dec 14, 2023 | LQDA Liquidia Corp | Director | Buy | 279,330 | $7.16 | $2,000,002.80 | New | +102.1% | +49.8% |